Home General and News updates NAFDAC to test non-US-made drugs, vaccines under Nigeria-US health deal

NAFDAC to test non-US-made drugs, vaccines under Nigeria-US health deal

0
148
    - Advertisement -

The National Agency for Food and Drug Administration and Control (NAFDAC) has assured Nigerians that donated medicines and vaccines supplied under the Nigeria-United States government agreement will remain subject to regulatory checks, including mandatory testing for products not manufactured in the US.

The agency said it would also deploy a technology-driven tracking system to monitor the movement and distribution of medical products provided under the agreement, as Nigeria seeks to sustain essential health interventions following the withdrawal of support from the United States Agency for International Development (USAID).

NAFDAC Director-General, Prof. Mojisola Christianah Adeyeye, disclosed this in a statement, explaining that medicines and vaccines manufactured in the US and approved by the US Food and Drug Administration (FDA) could receive expedited consideration under Nigeria’s existing regulatory-reliance framework.

- Advertisement - - Advertisement -



However, she stressed that the arrangement would not transfer Nigeria’s regulatory authority to the American agency.

“NAFDAC retains its responsibility for Nigeria’s own decision,” the agency stated, adding that products not manufactured in the US would be tested for quality, safety and efficacy.

The clarification comes as the Nigerian government seeks to maintain the supply of essential medicines, particularly those required for HIV/AIDS treatment, following changes in US development assistance.


NAFDAC said regulatory reliance was designed to reduce unnecessary duplication and speed up access to quality-assured medical products without weakening Nigeria’s safeguards.

The agency cited the position of the Coordinating Minister of Health and Social Welfare, Prof. Ali Pate, that regulatory reliance does not prevent NAFDAC from evaluating applications, inspecting products and manufacturing facilities, conducting risk-based tests, releasing vaccine batches and carrying out post-market surveillance where necessary.

According to NAFDAC, the memorandum of understanding between the United States and Nigerian governments refers to an existing arrangement under which products manufactured in the US and approved by the FDA may receive expedited regulatory consideration.

The agency maintained that it would continue to exercise its statutory responsibilities over medicines, vaccines and diagnostic products, regardless of the approval pathway used.

Tracking system to monitor medical supplies

To strengthen oversight, NAFDAC said it would use the GS1 technology-driven Track and Trace system to monitor medical products supplied under the agreement.

The agency said it deployed the technology to track COVID-19 vaccines during the pandemic, with the information retained in its Traceability Information System.

It added that the system had since been extended to non-COVID-19 vaccines, narcotics, maternal health supplies and newborn-care commodities.

“NAFDAC will use the same GS1 technology-driven Track and Trace system to monitor ALL medical products that come into the country under the USG-GoN Agreement,” the statement said.

The system is intended to improve visibility across the medical supply chain and help the agency monitor the distribution of products within Nigeria.

NAFDAC also cited its previous testing of COVID-19 vaccines supplied to Nigeria during the pandemic, noting that the products were tested at its Vaccine, Biologics and Medical Devices Laboratory in Yaba, Lagos, despite having been declared safe by the World Health Organisation.

The agency further disclosed that antiretroviral, tuberculosis and malaria medicines supplied through the Global Fund undergo annual testing.

Reaffirming its commitment to public health, NAFDAC said it would not abandon its statutory duty to protect Nigerians from unsafe or substandard medical products.

“As the Agency with the mandate to safeguard the health of Nigerians, NAFDAC will NOT fail to carry out this responsibility as enshrined in the mandate,” it stated.

The agency urged the public to remain confident that regulatory oversight, appropriate product testing and technology-driven monitoring would continue to guide its handling of medical supplies entering the country under the Nigeria-US agreement.

- Advertisement -

We do everything possible to supply quality news and information to all our valuable readers day in, day out and we are committed to keep doing this. Your kind donation will help our continuous research efforts.

-Advertisement-


-Want to get the news as it breaks?-

https://franktalknow.com/fire-guts-new-female-hostel-at-sokoto-varsity/